(Q57300220)

English

Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation

scientific article published on 04 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Martin Berg Johansen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Hans Erik Bøtker

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

D J Robertson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

M Maeng

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

A Kaltoft

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

L O Jensen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

H-H Tilsted

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

H T Sørensen

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

J A Baron

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

0 references

publication date

4 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

165-174

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

The Danish Civil Registration System.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Existing data sources for clinical epidemiology: The Western Denmark Heart Registry.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

The Danish Register of Causes of Death.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Clopidogrel-drug interactions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

The Influence of Proton Pump Inhibitors on the Antiplatelet Potency of Clopidogrel Evaluated by 5 Different Platelet Function Tests

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Cardiovascular and Gastrointestinal Outcomes in Clopidogrel Users on Proton Pump Inhibitors: Results of a Large Dutch Cohort Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Genetic determinants of response to clopidogrel and cardiovascular events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Review article: proton pump inhibitors with clopidogrel--evidence for and against a clinically-important interaction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Clopidogrel with or without omeprazole in coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Nonexperimental comparative effectiveness research using linked healthcare databases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Survival Bias Associated with Time-to-Treatment Initiation in Drug Effectiveness Evaluation: A Comparison of Methods

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04890.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2011.04890.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050009%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57300220&oldid=2135772867"